project id: TCGA-UCEC; case submitter id: TCGA-AX-A3FS; source center: 23; state: released; a260 a280 ratio: 1.8; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.8; rna integrity number: 8.7; age at index: 82; days to birth: -30102; ethnicity: not hispanic or latino; gender: female; race: white; vital status: Alive; year of birth: 1928; age at diagnosis: 30102; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 7.0; figo stage: Stage IA; icd 10 code: C54.1; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Endometrium; synchronous malignancy: No; tissue or organ of origin: Endometrium; tumor grade: Not Reported; year of diagnosis: 2010; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; weight: 20.0; composition: Not Reported; days to collection: 609; initial weight: 80.0; oct embedded: false; preservation method: Unknown; sample id: 272d64f9-0b4b-4136-adff-66c5401fc1d2; sample submitter id: TCGA-AX-A3FS-01A; portion id: b6acf7ab-b2d4-4e33-9755-338900ad0415; portion submitter id: TCGA-AX-A3FS-01A-11; slide id: 27ae39d9-679d-42d4-ad3a-2e4342d5243f; slide submitter id: TCGA-AX-A3FS-01A-01-TS1; percent lymphocyte infiltration: 1.0; percent monocyte infiltration: 0.0; percent necrosis: 10.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 5.0; percent tumor cells: 75.0; percent tumor nuclei: 95.0; section location: TOP;